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Abstract
Objective: To evaluate the performance of APR-DRG (All Patient Reﬁ  ned—Diagnosis Related Group) Risk of Mortality 
(ROM) score as a mortality risk adjustor in the intensive care unit (ICU).
Design: Retrospective analysis of hospital mortality.
Setting: Medical ICU in a university hospital located in metropolitan New York.
Patients: 1213 patients admitted between February 2004 and March 2006.
Main results: Mortality rate correlated signiﬁ  cantly with increasing APR-DRG ROM scores (p  0.0001). Multiple logis-
tic regression analysis demonstrated that, after adjusting for patient age and disease group, APR-DRG ROM was signiﬁ  cantly 
associated with mortality risk in patients, with a one unit increase in APR-DRG ROM associated with a 3-fold increase in 
mortality.
Conclusions: APR-DRG ROM correlates closely with ICU mortality. Already available for many hospitalized patients 
around the world, it may provide a readily available means for severity-adjustment when physiologic scoring is not 
available.
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Mortality rates vary widely across intensive care units (ICU) in large part attributable to variation 
in patient acuity and co-morbidities. Severity adjustment of outcomes data is required to track an 
ICU’s performance over time. For instance, if an ICU institutes a systematic change in practice and 
the mortality rate is unchanged, it is possible that the change in practice was effective but that the 
ICU severity also increased hiding the actual improvement in outcome. Also comparing an ICU’s 
outcome or cost utilization to another ICU or to an external benchmark requires a measure of its 
severity of illness.
Various ICU severity scores are in use. The Acute Physiology and Chronic Health Evaluation (APACHE) 
score ﬁ  rst developed in 1981 combined physiologic status at 24 hours after ICU admission, demographic 
information, primary ICU diagnosis and medical co-morbidities to determine severity of illness. After 
several modiﬁ  cations over the years, APACHE IV can calculate predicted mortality rates and ICU length 
of stay (Knaus et al. 1981; Knaus et al. 1985; Zimmerman et al. 2006). Simpliﬁ  ed Acute Physiology Score 
(SAPS) II utilizes 17 variables collected after 24 hours in the ICU. (Le Gall et al. 1993) It differs from 
APACHE in that it is not adjusted for primary ICU diagnosis. Mortality Probability Models (MPM) utilizes 
binary entry of 11 variables and is less physiologically based than APACHE or SAPS.(Lemeshow et al. 20
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1985) It can be calculated at 0, 24, or 48 hours after 
admission and returns a predicted mortality rate. 
Specialized scoring systems have been developed 
for speciﬁ  c ICU populations, for example trauma, 
pediatrics and cardiac surgery (Boyd et al. 1987; 
Balakrishnan et al. 1992; Tu et al. 1994).
Physiologic severity scoring requires dedicated 
personnel with specialized training to extract vital 
signs, laboratory values and determine the pri-
mary ICU admission diagnosis. Overall accuracy 
of APACHE scoring is high, but errors do 
occur (Polderman et al. 2001; Goldhill and 
Sumner, 1998; Arts et al. 2003; Gooder et al. 
1997). Utilizing personnel with years of clinical 
ICU experience improves the quality and accu-
racy of the data extraction. Reviews of severity 
adjustment have been published and the accu-
racy of various scoring systems accuracy 
has been directly compared. (Herridge, 2003; 
Castella et al. 1995).
Though severity scoring has been available 
for over 30 years, most ICUs in the United States 
do not routinely calculate severity adjusted out-
comes. This is likely due to the ﬁ  nancial cost 
and logistical burden of collecting physiologic 
data at the bedside. Typically one specially 
trained full-time employee per ICU is required 
to collect daily bedside information for each 
admission. A fully integrated system that 
includes an electronic medical record and a 
physiologic scoring system would minimize this 
cost, but few hospitals have access to an elec-
tronic medical record.
The All Patient Refined-Diagnosis Related 
Group (APR-DRG) methodology was developed 
by 3M to allow analysis of outcomes across large 
cohorts for a given diagnostic group (Iezzoni et al. 
1995). The APR-DRG scores are calculated from 
discharge billing codes and are based on primary 
and secondary discharge diagnosis, age, and pre-
existing medical conditions. In addition to other 
scores, APR-DRG ranks the risk of mortality 
(ROM) as low, medium, high, and extreme. This 
proprietary scoring system speciﬁ  cally excludes 
codes reﬂ  ecting in-hospital complications. There 
is a paucity of data regarding the APR-DRG meth-
odology in the ICU setting, and the accuracy of 
APR-DRG ROM for severity adjustment of ICU 
patients has not been reported.
In this paper we evaluated the performance of 
APR-DRG ROM as a mortality risk adjustor in 
the ICU.
Methods
Setting
Stony Brook University Medical Center’s Medical 
ICU is a 12 bed ICU in a 504 bed tertiary-care 
university hospital located in the metropolitan New 
York area. It is a closed ICU managed by board-
certiﬁ  ed pulmonary/critical care attendings who 
supervise medical housestaff and pulmonary/
critical care fellows.
Data
1213 patients admitted to the medical ICU between 
February 1, 2004 and March 31, 2006 were identi-
ﬁ  ed. Demographic and hospital discharge status 
were obtained.
APR-DRG ROM (3M, Version 20) was avail-
able through the University Hospital Consortium, 
as Stony Brook University Medical Center is a 
member of this organization. APR-DRG calcula-
tions are based on electronic bills submitted by the 
hospital at time of patient discharge after chart data 
extraction by certiﬁ  ed professional coders. Primary 
DRG billing diagnosis was identiﬁ  ed and divided 
into 5 groups: cardiology, gastroenterology, neurol-
ogy, pulmonary, and other.
Though ICU severity adjustment was not per-
formed routinely in our ICU, APACHE II scores 
were available for 165 patients admitted from April 
2004 through August 2004, and APACHE III 
scores were available for 204 patients admitted 
from April 2005 through August 2005 and from 
December 2005 through January 2006. APACHE 
II and APACHE III scores were performed by 
dedicated personnel. Scores were calculated 24 
hours post-ICU admission based on information 
in the medical record using standardized comput-
erized spreadsheets.
All data were fully de-identiﬁ  ed and the Stony 
Brook University Institutional Review Board 
approved the project.
Statistical analysis
The demographic information was summarized by 
descriptive statistics (means and standard devia-
tions for continuous variables, and frequencies 
and percentages for categorical variables). Disease 
group-speciﬁ  c mortality rates for different APR-
DRG ROM score levels were also calculated. Using 
ROM “Low” as the reference group, in-hospital 21
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mortality odds ratios (OR) and their 95% conﬁ  dence 
intervals (CI) for other ROM categories (“Moder-
ate”, “High”, and “Extreme”) were calculated. The 
Cochran-Armitage test (Agresti, 2002) was used 
to evaluate the linear trend between ROM scores 
and mortality rates. With ROM score as a continu-
ous predictor, we obtained the average OR (95% 
CI) using logistic regression analysis. Area under 
the receiver operating characteristics (ROC) curve 
(AUC) was also calculated.
Multivariable logistic models were developed 
to further evaluate the mortality predictive power 
of APR-DRG ROM, while adjusting for other 
covariates, including age, gender, and disease 
groups. The possible 2-way interaction terms 
among these four variables were also considered 
in the model building process using the likelihood 
ratio test (LRT). The model discrimination and 
calibration were evaluated by the AUC and 
Hosmer-Lemeshow goodness-of-ﬁ  t (GOF) test, 
respectively. The performances of candidate mod-
els were evaluated using 5-fold cross-validation 
(Zhang, 1993). Data from all patients were ﬁ  rst 
randomly grouped into 5 subsets of equal size. 
Each of the 5 subsets was in turn treated as a vali-
dation set with the remaining 4 subsets as the 
training set. Thus, there were ﬁ  ve pairs of training 
sets and testing sets. The regression coefﬁ  cient 
estimates based on the current training set were 
used to calculate the predicted probabilities of 
death for the current testing set. These predicted 
mortality rates were used to compute the AUC and 
Hosmer-Lemeshow goodness-of-ﬁ  t (GOF) test 
p-value for the current testing set(Hosmer, 2000). 
The ﬁ  ve validated AUC values were used to pro-
duce each model’s cross-validated statistics and its 
standard deviation. AUC values between (0.70, 
0.80) were considered acceptable discrimination; 
while AUC 0.80 was considered excellent dis-
crimination (Hosmer and Lemeshow, 2000). All 
statistical analyses were performed in SAS 9.1 and 
a two-sided p-value of less than 0.05 was treated 
as statistically signiﬁ  cant.
Results
APR-DRG ROM scores of 1213 patients were 
included in the analysis. Of these, 165 had 
APACHE II scores (range 2–43, with a mean of 
20.7 and a standard deviation of 7.8) and 204 had 
APACHE III scores (range 8–209, with a mean of 
65.7 and a standard deviation of 30.6). Of the 1213 
patients, the mean (SD) age was 62.2 years (18.3 
years) and 46.6% (n = 565) were females.
The association of mortality and APR-DRG 
ROM scores was consistent within various disease 
groups, i.e. higher APR-DRG ROM scores tended 
to be associated with increased mortality (Table 1). 
The crude odds ratios of two higher levels (“High” 
and “Extreme”) of APR-DRG ROM scores are 
statistically signiﬁ  cantly higher than the “Low” 
ROM score (OR for “High vs. Low”= 10.15 [95% 
CI: 3.13,32.86]; OR for “Extreme vs. Low” = 32.57 
[95% CI: 10.24,103.58]), although the difference 
between level “Moderate” and level “Low” was 
less dramatic (OR for “Moderate vs. Low” = 2.90 
[95% CI: 0.79,10.59]) (Fig. 1). The linear trend 
between ROM scores and in-hospital mortality 
rates was highly signiﬁ  cant based on the Cochran-
Armitage test (p  0.0001). When the four levels 
of APR-DRG ROM scores were treated as a con-
tinuous predictor in a simple logistic regression 
model, one unit of increase in APR-DRG ROM 
was associated with an average 3.26-fold increase 
in mortality rate, with a 95% conﬁ  dence interval 
of (2.64, 4.03) (p-value  0.0001). The associated 
AUC was 0.733 for APR-DRG ROM, an accept-
able discrimination.
To adjust for other relevant covariates, i.e. age, 
gender and disease group, multivariable logistic 
models were developed. Possible 2-way interaction 
terms among the above four predictors were not 
statistically signiﬁ  cant in the model building pro-
cess based on LRTs. Neither was the main effect 
of gender. Therefore, there were 4 candidate mod-
els to be considered. Performance of these candi-
date models, based on ﬁ  ve-fold cross-validation 
analysis and model selection results, are summa-
rized in Table 2.
The overall best model, in terms of LRT, dis-
crimination (average cross-validation AUC for 
testing set) and calibration (the Hosmer-Lemeshow 
goodness of ﬁ  t p-value for testing set), was Model 
D with APR-DRG ROM, age, and disease groups 
as predictors. All three predictors in Model D were 
signiﬁ  cant based on LRT, suggesting that APR-DRG 
ROM, age, and disease groups were all signiﬁ  cantly 
and independently associated with mortality risk in 
patients. The ﬁ  ve-fold cross-validation results from 
Model D showed an average AUC of 0.762 with the 
smallest standard deviation of 0.021, Based on all 
available data, the adjusted odd ratio (95% CI) of 
APR-DRG ROM score for Model D was 3.01 (2.40, 
3.76), and the AUC value was 0.782.22
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Discussion
The APR-DRG ROM performed very well in 
grouping our ICU patients with signiﬁ  cantly dif-
ferent mortality rates and provided acceptable 
discrimination in regards to mortality. This sug-
gests APR-DRG ROM may be a useful means for 
severity adjustment in the ICU.
The AUC for APR-DRG ROM was 0.733. In a 
large international study with over 14,000 patients, 
the AUC for APACHE, MPM, and SAPS, AUC 
ranged from 0.766–0.861(Castella et al. 1995); 
newer scoring systems were shown to have 
improved discrimination than older. In our study, 
based on relatively small subset of patients who 
had APACHE scoring, APACHE II and APACHE 
III provided either similar or slightly more dis-
criminative power than APR-DRG ROM in regards 
to mortality rate, with AUC = 0.768 for APACHE 
II (n = 165) and AUC = 0.829 for APACHE III 
(n = 204). That APACHE was better calibrated than 
APR-DRG ROM is not surprising as it was spe-
ciﬁ  cally designed for critically ill patients, whereas 
APR-DRG was calibrated for patients across a 
wider spectrum of acuity. Addition of age and 
disease group increased the APR DRG ROM AUC 
up to 0.782; perhaps future calibration with larger 
datasets would increase the AUC up into the range 
of the more established scoring systems.
APR-DRG ROM differs from APACHE and 
most other ICU severity scoring methodologies in 
several important ways. First APR-DRG ROM is 
calculated after hospital discharge; other scoring 
systems are calculated within 24 or 48 hours of 
ICU admission. Therefore the APR-DRG ROM 
cannot be calculated at time of ICU admission and 
cannot be used by the clinician caring for the 
patient. MPM and APACHE IV allow for repeat 
assessments which may provide the bedside prac-
titioner an assessment of patient status; APR DRG 
ROM can not provide this.
Second, APR-DRG ROM was designed to cor-
relate with survival to hospital discharge, not ICU 
mortality. Earlier scoring systems predicted ICU 
mortality, such that patients who were discharged 
from the ICU but died prior to hospital discharge 
were considered survivors. As many patients des-
tined to die are transitioned to non-ICU care at the 
end of their hospital course, the distinction between 
ICU and hospital mortality becomes blurred.
Lastly, the major difference between APR-DRG 
ROM and other ICU severity scoring systems is 
that calculation of APR-DRG ROM does not 
require dedicated personnel and resources for ICU 
data collection. Scoring is calculated using coding 
information available for all U.S. hospital dis-
charges. At present 1500 hospitals utilize the APR-
DRG methodology, and therefore APR-DRG ROM 
scores are already currently being calculated for a 
large number of ICU patients. These scores could 
be used to severity adjust ICU outcomes, however 
they are not being reported back to the ICU. All 
other ICU scores require entry of physiologic sta-
tus; this requires dedicated personnel for data 
extraction from the bedside record.
Table 1. Summary of mortality rates for different APR-DRG Risk of Mortality (ROM) levels and ﬁ  ve disease 
groups.
Disease ROM = Low ROM = Moderate ROM = High ROM = Extreme
Group (n) dead total mortality 
%
dead total mortality 
%
dead total mortality 
%
dead total mortality 
%
Cardiology
(113) 0 2 0.0 0 14 0.0 7 45 15.6 22 52 42.3
Gastroenterology 
(172) 0 33 0.0 0 38 0.0 6 52 11.5 17 49 34.7
Neurology
(94) 0 8 0.0 3 14 21.4 7 19 36.8 34 53 64.2
Pulmonary
(261) 2 32 6.3 4 46 8.7 16 101 15.8 36 82 43.9
Other
(573) 1 72 1.4 4 81 4.9 27 144 18.8 98 276 35.5
Total
(1213) 3 147 2.0 11 193 5.7 63 361 17.5 207 512 40.423
APR-DRG risk of mortality in the ICU
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Professional coders extract chart data for 
purposes of billing, reimbursement, and quality 
assurance initiatives. Though coding accuracy is 
dependent on the expertise of the coder, tightly 
regulated coding laws and credentialing serve to 
limit variation in practice and accuracy (Campbell 
et al. 2001). Hospitals have an interest in accurate 
coding as it is the primary determinant of 
reimbursement and there are signiﬁ  cant ﬁ  nancial 
and operational penalties for improper coding. 
Though the DRG coding system was initially 
designed in the United States by the Social Security 
Administration for use in Medicare reimbursement 
(Scott, 1984), it has become increasingly used in 
Europe and elsewhere. Per the 3M corporate 
website, the APR-DRG methodology is being used 
in over 26 countries worldwide.
The APR-DRG is marketed to hospital as a 
means to benchmark their overall performance and 
resource utilization. It allows comparison of how 
a given institution is performing for a selected 
DRG, such as its performance in caring for patients 
with pneumonia. Several states require utilization 
of the APR-DRG methodology for all hospital 
discharges in order to allow comparison between 
hospitals. Despite its widespread use, there is little 
in the peer-reviewed literature regarding APR-
DRG and there are no papers describing its valid-
ity or accuracy in the ICU setting.
There are several limitations in the analysis. Our 
data only include patients in a single medical ICU; 
APR-DRG ROM may perform differently in dif-
ferent patient populations such those caring for 
surgical or pediatric patients. In certain subgroups, 
clinical issues are often a prime determinant of 
outcome, such as pre-operative left ventricular 
function in cardiac surgery patients. As the APR-
DRG methodology does not factor clinical vari-
ables, it may not perform as well as dedicated 
scoring systems for these patients.
Use of the APR-DRG ROM score as a severity 
of illness adjustor in the ICU requires validation 
with much larger populations and across hospitals. 
Studies comparing other methodologies have shown 
signiﬁ  cant variation across hospitals (Knaus et al. 
1993; Sirio et al. 1999; Render et al. 2005). Ques-
tions remain how much of this variation is from true 
differences in outcome and how much is dependant 
Figure 1. Comparison of mortality rates among different APR-DRG ROM scoring categories.
Notes: *Mortality odds ratios and their 95% conﬁ  dence intervals for ROM categories (“Moderate”, “High”, and “Extreme”), using ROM “Low” 
category as the reference group.
**Number of deaths and number of subjects for each ROM category included in the analysis.
Low Moderate High Extreme
M
o
r
t
a
l
i
t
y
 
(
%
)
0
.
0
0
.
1
0
.
2
0
.
3
0
.
4
0
.
5
0
.
6
(3/147)** (11/193)** (63/361)** (207/512)**
2.90 [0.79,10.59]*
10.15 [3.13,32.86]*
32.57 [10.24,103.58]*24
Baram et al
Clinical Medicine: Circulatory, Respiratory and Pulmonary Medicine 2008:2 
on the scoring system utilized (Puri, 2005; Capuzzo 
et al. 2000; McNelis et al. 2001; Beck et al. 2003; 
Schafer et al. 1990; Iezzoni et al. 1995).
Despite reservations regarding severity adjust-
ment, there are growing calls to benchmark ICU 
outcomes and to report severity adjusted mortality 
(Garland, 2005; Sirio, 2006; Combes et al. 2005; 
Gupta et al. 2002), and organizations such as The 
Joint Commission on Accreditation of Healthcare 
Organizations (JCAHO) and the Leapfrog Group 
are interested in standardizing ICU severity adjust-
ment (Afessa et al. 2005). With the increasing 
pressure to standardize ICU protocols and care, it 
is important that we accurately measure severity-
adjusted outcomes to ensure that these protocols 
are not improving one aspect of care at the cost of 
another.
Conclusions
APR-DRG ROM correlates closely with ICU 
mortality. As this score is already available in many 
hospitals around the world, it provides a readily 
available means for severity-adjusting ICU outcomes 
when physiologic scoring is not available.
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